Hims & Hers stock skyrockets 40% as Novo Nordisk ends feud, agrees to sell Ozempic and Wegovy on platformMarch 9, 2026
Share Facebook Twitter LinkedIn Pinterest Email Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant. agrees amp ends feud Hims Nordisk Novo Ozempic platform Sell skyrockets stock Wegovy
‘I don’t own a home’: I’m 62, unemployed and have $1.5 million for retirement. Can I afford to divorce my husband?March 8, 2026
